| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |